aDepartment of Sociomedical Sciences, Columbia University Mailman School of Public Health, New York, NY;
bDepartment of Sociology, American University, Washington, DC;
cDivision of Biostatistics, Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL;
dDepartment of Medicine/CORE Center, Cook County Health & Hospital System, John H. Stroger Jr Hospital of Cook County, Chicago, IL;
eDepartment of Medicine, Montefiore, Bronx, NY;
fDepartment of Medicine, Emory University School of Medicine, Atlanta, GA;
gDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC;
hDivision of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC;
iDepartment of Clinical Pharmacy, University of California at San Francisco School of Pharmacy, San Francisco, CA;
jDepartment of Medicine, Georgetown University Medical Center, Washington, DC; and
kDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Correspondence to: Morgan M. Philbin, PhD, MHS, Columbia University Mailman School of Public Health, 722 West 168th Street, Room 536, New York, NY 10032 (e-mail: [email protected]).
The WIHS is funded primarily by the National Institute of Allergy and Infectious Diseases (NIAID), with additional cofunding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Cancer Institute (NCI), the National Institute on Drug Abuse (NIDA), and the National Institute of Mental Health (NIMH). Targeted supplemental funding for specific projects is also provided by the National Institute of Dental and Craniofacial Research (NIDCR), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Institute on Deafness and Other Communication Disorders (NIDCD), and the NIH Office of Research on Women's Health. WIHS data collection is also supported by UL1-TR000004 (UCSF CTSA), P30-AI-050409 (Atlanta CFAR), P30-AI-050410 (UNC CFAR), and P30-AI-027767 (UAB CFAR). Dr. Philbin is supported by K01DA039804A.
Presented at: International AIDS Society Conference; July 23–28, 2018; Amsterdam, the Netherlands.
A.A.A. has received funding from Viiv, Merck, and Gilead, including a grant from Gilead; A.N.S. declares that Gilead has given research grants to her institution, but none are related to her current work. The remaining authors have no funding or conflicts of interest to disclose.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.jaids.com).
